{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:22:21Z","timestamp":1793460141566,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,5,28]],"date-time":"2010-05-28T00:00:00Z","timestamp":1275004800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00432-010-0907-7","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T04:29:38Z","timestamp":1274934578000},"page":"1117-1124","source":"Crossref","is-referenced-by-count":231,"title":["Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases"],"prefix":"10.1007","volume":"136","author":[{"given":"O.","family":"Filleul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Crompot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Saussez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,28]]},"reference":[{"key":"907_CR1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.joms.2008.01.038","volume":"66","author":"MR Allen","year":"2008","unstructured":"Allen MR, Burr DB (2008) Mandible matrix necrosis in beagle dogs after 3\u00a0years of daily bisphosphonate treatment. J Oral Maxillofac Surg 66:987\u2013994","journal-title":"J Oral Maxillofac Surg"},{"key":"907_CR2","doi-asserted-by":"crossref","unstructured":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws (2007) J Oral Maxillofac Surg 65:369\u2013376","DOI":"10.1016\/j.joms.2006.11.003"},{"key":"907_CR3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tripleo.2007.08.040","volume":"105","author":"A Bedogni","year":"2008","unstructured":"Bedogni A, Blandamura S, Lokmic Z, Palumbo C, Ragazzo M, Ferrari F et al (2008) Bisphosphonate-associated jawbone osteonecrosis : a correlation between imaging techniques and histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:358\u2013364","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"907_CR4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","volume":"67","author":"ER Carlson","year":"2009","unstructured":"Carlson ER, Basile JD (2009) The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 67:85\u201395","journal-title":"J Oral Maxillofac Surg"},{"key":"907_CR5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1834-7819.2005.tb00384.x","volume":"50","author":"A Cheng","year":"2005","unstructured":"Cheng A, Mavrokokki A, Carter G, Stein B, Fazzalari NL, Wilson DF et al (2005) The dental implications of bisphosphonates and bone disease. Aust Dent J 50:4\u201313","journal-title":"Aust Dent J"},{"key":"907_CR6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.joms.2005.12.051","volume":"65","author":"MM Curi","year":"2007","unstructured":"Curi MM, Cossolin GSI, Koga DH, Ara\u00f9jo SR, Feher O, dos Santos MO et al (2007) Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: report of 3 cases. J Oral Maxillofac Surg 65:349\u2013355","journal-title":"J Oral Maxillofac Surg"},{"key":"907_CR7","first-page":"504","volume":"136","author":"C Dannemann","year":"2006","unstructured":"Dannemann C, Gr\u00e4tz KW, Zwahlen R (2006) Clinical experience with bisphosphonate-induced osteochemonecrosis of the jaw. Swiss Med Wkly 136:504\u2013509","journal-title":"Swiss Med Wkly"},{"key":"907_CR8","doi-asserted-by":"crossref","first-page":"516","DOI":"10.4065\/82.4.516","volume":"82","author":"BGM Durie","year":"2007","unstructured":"Durie BGM (2007) Use of bisphosphonates in multiple myeloma: IMWG response to Mayo Clinic consensus statement. Mayo Clin Proc 82:516\u2013517","journal-title":"Mayo Clin Proc"},{"key":"907_CR9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","volume":"353","author":"BGM Durie","year":"2005","unstructured":"Durie BGM, Katz M, Crowley J (2005) Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353:99\u2013102","journal-title":"N Engl J Med"},{"key":"907_CR10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.joms.2005.01.010","volume":"63","author":"JW Hellstein","year":"2005","unstructured":"Hellstein JW, Marek CL (2005) Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 63:682\u2013689","journal-title":"J Oral Maxillofac Surg"},{"key":"907_CR11","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1200\/JCO.2007.12.1269","volume":"25","author":"RA Kyle","year":"2007","unstructured":"Kyle RA, Yee GC, Somerfield MR, Flynn PJ, Halabi S, Jagannath S et al (2007) American society of clinical oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J Clin Oncol 25:2464\u20132472","journal-title":"J Clin Oncol"},{"key":"907_CR12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tripleo.2005.10.045","volume":"102","author":"AF Leite","year":"2006","unstructured":"Leite AF, Figueiredo PT, Melo NS, Acevedo AC, Cavalcanti MG, Paula M et al (2006) Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:14\u201321","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"907_CR13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0278-2391(03)00430-0","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofacial Surg 61:115\u2013117","journal-title":"J Oral Maxillofacial Surg"},{"key":"907_CR14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","volume":"65","author":"T Mavrokokki","year":"2007","unstructured":"Mavrokokki T, Cheng A, Stein B, Goss A (2007) Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65:415\u2013423","journal-title":"J Oral Maxillofac Surg"},{"key":"907_CR15","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/02841860601185917","volume":"46","author":"C Ortega","year":"2007","unstructured":"Ortega C, Montemurro F, Faggiulo R et al (2007) Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis. Acta Oncol (Madr) 46:664\u2013668","journal-title":"Acta Oncol (Madr)"},{"key":"907_CR16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/10428190600977690","volume":"48","author":"S Pozzi","year":"2007","unstructured":"Pozzi S, Marcheselli R, Sacchi S, Baldini L, Angrilli F, Pennese E et al (2007) Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients. Leuk Lymphoma 48:56\u201364","journal-title":"Leuk Lymphoma"},{"key":"907_CR17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tripleo.2006.06.004","volume":"102","author":"SL Ruggiero","year":"2006","unstructured":"Ruggiero SL, Fantasia J, Carlson E (2006) Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:433\u2013441","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"907_CR18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/lary.20076","volume":"119","author":"S Saussez","year":"2009","unstructured":"Saussez S, Javadian R, Hupin C, Magremanne M, Chantrain G, Loeb I et al (2009) Bisphosphonate-related osteonecrosis of the jaws and its associated risk factors: a Belgian case series. Laryngoscope 119:323\u2013329","journal-title":"Laryngoscope"},{"key":"907_CR19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/pho.2007.2181","volume":"26","author":"P Vescovi","year":"2008","unstructured":"Vescovi P, Merigo E, Manfredi M, Meleti M, Fornaini C, Bonanini M et al (2008) Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaws: clinical experience in 28 cases. Photomed Laser Surg 26:37\u201346","journal-title":"Photomed Laser Surg"},{"key":"907_CR20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00520-006-0120-z","volume":"15","author":"C Walter","year":"2007","unstructured":"Walter C, Gr\u00f6tz KA, Kunkel M, Al-Nawas B (2007) Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis. Support Care Cancer 15:197\u2013202","journal-title":"Support Care Cancer"},{"key":"907_CR21","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.joms.2007.03.006","volume":"65","author":"EP Wang","year":"2007","unstructured":"Wang EP, Kaban LB, Strewler GJ, Raje N, Troulis MJ (2007) Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. J Oral Maxillofac Surg 65:1328\u20131331","journal-title":"J Oral Maxillofac Surg"},{"key":"907_CR22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","volume":"144","author":"SB Woo","year":"2006","unstructured":"Woo SB, Hellstein JW, Kalmar JR (2006) Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753\u2013761","journal-title":"Ann Intern Med"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-010-0907-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-010-0907-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-010-0907-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T11:06:44Z","timestamp":1559128004000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-010-0907-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,28]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["907"],"URL":"https:\/\/doi.org\/10.1007\/s00432-010-0907-7","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,28]]}}}